The Patent Finder

Celera Corporation

46 patents currently held · Updated Nov 21, 2026
8 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

Recorded under 3 name spellings.

34
Ending by 2030
May 2027
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Nov 28, 2026
    The maintenance fee for Genetic polymorphisms, associated with rheumatoid arthritis, methods of detection and uses thereof (US 10,301,679) comes due Nov 28, 2026. Unpaid by May 28, 2027, it lapses early.
  • 3 fees due Jan 2 to 11, 2027 · next Jan 2
  • 3 fees due Apr 8 to 30, 2027 · next Apr 8
  • 2 fees due May 14 to 28, 2027 · next May 14
  • 2 fees due Aug 4 to 18, 2027 · next Aug 4
  • 1 fee due Sep 10, 2027
    The maintenance fee for Genetic polymorphisms associated with cardiovascular diseases, methods of detection and uses thereof (US 10,584,384) comes due Sep 10, 2027. Unpaid by Mar 10, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 8,486,392Methods and compositions for diagnosing and treating diseases
In force
 · USPTO record
In forceUSPTO record
US 8,975,022Genetic Polymorphisms Associated with Psoriasis, Methdos of Detection and Uses Thereof
In force
 · Medium confidence
In forceMedium confidence
US 9,371,565Genetic polymorphisms associated with psoriasis, methods of detection and uses thereof
In force
 · USPTO record
In forceUSPTO record
US 10,006,088Genetic polymorphisms associated with psoriasis, methods of detection and uses thereof
In force
 · USPTO record
In forceUSPTO record
US 10,920,276Genetic polymorphisms associated with psoriasis, methods of detection and uses thereof
In force
 · USPTO record
In forceUSPTO record
US 10,988,809Genetic polymorphisms associated with coronary events and drug response, methods of detection and uses thereof
In force
 · USPTO record
In forceUSPTO record
US 11,814,684Genetic polymorphisms associated with coronary events and drug response, methods of detection and uses thereof
In force
 · USPTO record
In forceUSPTO record
US 10,550,433Polymorphism in the Apo(A) Gene Predict Responsiveness to Acetylsalicylic Acid Treatment
In force
 · High confidence
In forceHigh confidence
US 11,028,445Molecular prognostic signature for predicting breast cancer metastasis, and uses thereof
In force
 · USPTO record
In forceUSPTO record
US 7,727,725Genetic polymorphisms associated with liver fibrosis, methods of detection and uses thereof
In force
 · USPTO record
In forceUSPTO record
10 of 46 patents shown.
Pro members see all 46.
Pro members: see all 46 patents
Also on record, not counted in the 46: 8 patents in force now held by others · 250 lapsed for an unpaid fee · 14 ended at full term. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

3 pending · 31 abandoned · 73 no status recorded

Showing 1 to 10 of 107, newest filing first. An application has no patent term. A term is computed when and if it grants, and appears on that patent's own page. Where no title is shown, the bulk publication record carries none and this site holds no USPTO file history for that application.

ApplicationTitleFiledStatus
18/813,957Aug 23, 2024No status recorded
18/779,321Jul 22, 2024No status recorded
18/314,038Automated Circuit GenerationMay 8, 2023Pending
18/177,065Automated Verification of Integrated CircuitsMar 1, 2023Pending
17/894,038Automated Verification of Integrated CircuitsAug 23, 2022Pending
17/852,737Jun 29, 2022No status recorded
17/668,697Feb 10, 2022No status recorded
17/152,136Jan 19, 2021Abandoned
17/143,421Kidney Disease Targets and Uses ThereofJan 7, 2021Abandoned
17/140,716Jan 4, 2021No status recorded
10 of 107 applications shown.
Pro members see all 107 published applications.
Pro members: see all 107 applications
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited